SG Americas Securities, LLC
Broker-DealerPosition in CLDX — Celldex Therapeutics, Inc.
CIK 1313360
NEW YORK, NY
Position in CLDX
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$293,549
-$912,064 QoQ
Shares Held
7,889
-79.2% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#165
of 252 holders
Holding Since
Dec 2020
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CLDX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026SG Americas Securities, LLC holds $1,085,838,933 across 181 Biotechnology names. CLDX ranks #119 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
427,703 | $266,689,928 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
523,720 | $260,147,435 | |
| 3 | URGN |
UroGen Pharma Ltd.
|
2,052,906 | $75,546,940 | |
| 4 | CGON |
CG Oncology, Inc.
|
867,465 | $61,633,388 | |
| 5 | PTCT |
Ptc Therapeutics, Inc.
|
605,581 | $49,397,242 | |
| 6 | ASND |
Ascendis Pharma A/S
|
161,026 | $42,948,854 | |
| 7 | RPRX |
Royalty Pharma plc
|
688,590 | $38,609,241 | |
| 8 | BNTX |
BioNTech SE
|
347,131 | $32,300,539 |
All Filings in CLDX
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $293,549 | 7,889 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $1,205,613 | 38,008 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $1,285,754 | 47,340 | Shares | Sole | 2026-01-09 | |
| 2025-09-30 | $503,637 | 19,468 | Shares | Sole | 2025-10-23 | |
| 2025-03-31 | $633,144 | 34,884 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $638,901 | 25,283 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $690,540 | 20,316 | Shares | Sole | 2024-10-03 | |
| 2024-06-30 | $334,718 | 9,044 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $850,983 | 20,276 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $1,827,651 | 46,083 | Shares | Sole | 2024-01-12 | |
| 2023-09-30 | $2,146,862 | 78,011 | Shares | Sole | 2023-10-13 | |
| 2023-06-30 | $167,342 | 4,932 | Shares | Sole | 2023-07-10 | |
| 2023-03-31 | $373,796 | 10,389 | Shares | Sole | 2023-04-28 | |
| 2022-12-31 | $303,165 | 6,802 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $367,341 | 13,068 | Shares | Sole | 2022-10-31 | |
| 2022-06-30 | $1,503,154 | 55,755 | Shares | Sole | 2022-07-29 | |
| 2022-03-31 | $475,477 | 13,960 | Shares | Sole | 2022-04-29 | |
| 2021-12-31 | $389,761 | 10,087 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $1,056,800 | 19,574 | Shares | Sole | 2021-11-01 | |
| 2020-12-31 | $439,804 | 25,103 | Shares | Sole | 2021-02-04 | |
| No filing history on record for this holder in this stock. | ||||||